Abstract
Background and Objective: Lung cancer poses a significant global burden of disease, and whilst surgical and oncological therapies have revolutionised management, post-treatment recurrence remains a hurdle. Though there is no universal consensus which agrees upon a follow-up regime for these patients, evidence supports use of radiological imaging to monitor disease recurrence and progression. Through this narrative review, our objective is to compare current guidelines on follow-up and review the optimal imaging modality for follow up in lung cancer patients allowing for a more up to date review.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
